Marco Hofmann

Company: Boehringer Ingelheim
Job title: Director - Scientific & Group Leader
Seminars:
Development of KRAS Inhibitors – Updated from Boehringer Ingelheim 10:30 am
day: Day One
Company: Boehringer Ingelheim
Job title: Director - Scientific & Group Leader
day: Day One